Polypeptide compounds for inhibiting angiogenesis and tumor growth

Details for Australian Patent Application No. 2005224081 (hide)

Owner VasGene Therapeutics, Inc.

Inventors Zozulya, Sergey; Gill, Parkash; Reddy, Ramachandra; Krasnoperov, Valery; Kertesz, Nathalie

Agent Shelston IP

Pub. Number AU-B-2005224081

PCT Pub. Number WO2005/090406

Priority 10/949,720 23.09.04 US; 10/800,350 12.03.04 US; 60/612,908 23.09.04 US

Filing date 11 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 30 June 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090406 Priority application(s): WO2005/090406

30 June 2011 Application Accepted

  Published as AU-B-2005224081

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224082-Sleeve assembly for digital media disk

2005224079-Process for the synthesis of a CXCR4 antagonist